Ozempic and Trulicity: Top Medicare Drug Spending Revealed in AARP Report - PRESS AI WORLD
PRESSAI
Recent Posts
side-post-image
side-post-image
Economy

Ozempic and Trulicity: Top Medicare Drug Spending Revealed in AARP Report

share-iconThursday, January 09 comment-icon1 week ago 12 views
News sources:
usatodayUSATODAY
Ozempic and Trulicity: Top Medicare Drug Spending Revealed in AARP Report

Credited from: USATODAY

  • Ozempic and Trulicity are listed as two of the priciest drugs under Medicare, according to a report from the AARP Public Policy Institute.
  • These drugs have contributed nearly $50 billion in costs to Medicare in 2022, with average list prices having nearly doubled since their market introduction.
  • Of the 53 million Americans enrolled in Medicare, many struggle to afford their medications, leading to skipped doses or unfilled prescriptions.
  • The Inflation Reduction Act allows Medicare to negotiate drug prices, with expected discounts ranging from 38% to 79% starting in 2026.
  • AARP highlights the ongoing problem of price hikes and calls for enhanced negotiation powers for Medicare to better protect consumers.

For the full article, visit USA Today.

SHARE THIS ARTICLE:

nav-post-picture
nav-post-picture